Diagnosis and Management of Deep Venous Thrombosis and Pulmonary Embolism in Neonates and Children

Abstract

Neonates and children represent a specific population that can suffer from deep venous thrombosis (DVT) and pulmonary embolism (PE). In considering how the diagnosis and management of DVT/PE in neonates and children differs from adults, one has to consider the fundamental differences in the general characteristics of the patient population, the specific differences in the disease entity, the differences in sensitivity or specificity of diagnostic strategies and risk/benefit profile of therapeutic options available, and then finally the practical applications of therapies, using an evidence-based approach. This review will articulate the key differences in the patient population, disease entity, diagnostic strategies, and drug therapies that must be understood to apply a rigorous evidence-based approach to diagnosis and management of DVT and PE in neonates and children. Finally, there will be a brief discussion of the latest American College of Chest Physician guidelines for antithrombotic treatment in neonates and children.

Keywords

deep vein thrombosis - pulmonary embolism - anticoagulation - neonates - children

• References

• 1 Monagle P, Chan AK, Goldenberg NA , et al. Antithrombotic Therapy in Neonates and Children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl) e737S-801S
• 2 Schedin-Weiss S, Richard B, Hjelm R, Olson ST. Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence. Biochemistry 2008; 47 (51) 13610-13619
• 3 Forsten KE, Fannon M, Nugent MA. Potential mechanisms for the regulation of growth factor binding by heparin. J Theor Biol 2000; 205 (2) 215-230
• 4 Klagsbrun M. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin Cancer Biol 1992; 3 (2) 81-87
• 5 Rivera JC, Sapieha P, Joyal JS , et al. Understanding retinopathy of prematurity: update on pathogenesis. Neonatology 2011; 100 (4) 343-353
• 6 Xu X, Dai Y. Heparin: an intervenor in cell communication. J Cell Mol Med 2010; 14 (1–2) 175-180
• 7 Monagle P, Barnes C, Ignjatovic V , et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95 (2) 362-372
• 8 Ignjatovic V, Mertyn E, Monagle P. The coagulation system in children: developmental and pathophysiological considerations. Semin Thromb Hemost 2011; 37 (7) 723-729
• 9 Niessen RW, Lamping RJ, Peters M, Lamers WH, Sturk A. Fetal and neonatal development of antithrombin III plasma activity and liver messenger RNA levels in sheep. Pediatr Res 1996; 39 (4 Pt 1) 685-691
• 10 Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12 (1) 95-104
• 11 Andrew M, Paes B, Milner R , et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70 (1) 165-172
• 12 Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992; 80 (8) 1998-2005
• 13 Ignjatovic V, Kenet G, Monagle P ; Perinatal and Paediatric Haemostasis Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Developmental hemostasis: recommendations for laboratories reporting pediatric samples. J Thromb Haemost 2012; 10 (2) 298-300
• 14 Newall F, Chan AK, Ignjatovic V, Monagle P ; Perinatal and Paediatric Haemostasis Subcommittee of the Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis. Recommendations for developing uniform laboratory monitoring of heparinoid anticoagulants in children. J Thromb Haemost 2012; 10 (1) 145-147
• 15 Monagle P, Chan A, de Veber G, Massicotte P. Developmental Hemostasis. Pediatric Thromboembolism and Stroke Handbook, 3rd ed. Hamilton, Ontario: BC Decker Inc; 2006: 3-30
• 16 Ignjatovic V, Lai C, Summerhayes R , et al. Age-related differences in plasma proteins: how plasma proteins change from neonates to adults. PLoS ONE 2011; 6 (2) e17213
• 17 Lisman T, Platto M, Meijers JC, Haagsma EB, Colledan M, Porte RJ. The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver. Blood 2011; 117 (6) 2070-2072
• 18 Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007; 109 (8) 3161-3172
• 19 Monagle P. Who controls the controllers?. Blood 2011; 117 (6) 1778-1779
• 20 Monagle P, Newall F. Anticoagulation in children. Thromb Res 2012; 130 (2) 142-146
• 21 Smith BA, Shuchman M. Problem of nonadherence in chronically ill adolescents: strategies for assessment and intervention. Curr Opin Pediatr 2005; 17 (5) 613-618
• 22 Goldenring J, Rosen D. Getting into adolescent heads. Contemp Pediatr 2004; 21 (1) 64-90
• 23 Patton GC, Coffey C, Sawyer SM , et al. Global patterns of mortality in young people: a systematic analysis of population health data. Lancet 2009; 374 (9693) 881-892
• 24 Jones S, Mertyn E, Alhucema P, Monagle P, Newall F. HEEADSSS assessment for adolescents requiring anticoagulation therapy. Arch Dis Child 2012; 97 (5) 430-433
• 25 White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 (23 Suppl 1) I4-I8
• 26 Andrew M, David M, Adams M , et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83 (5) 1251-1257
• 27 Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics 2009; 124 (4) 1001-1008
• 28 van Ommen CH, Heijboer H, Büller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001; 139 (5) 676-681
• 29 Gibson B, Chalmers E, Bolton-Maggs P, Henderson D, Lynne R. Thrombembolism in Childhood: A prospective 2.  year BPSU study in the United Kingdom. Thromb Haemost 2003; 1 (Suppl 1) OC422
• 30 Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96 (5 Pt 1) 939-943
• 31 Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76 (3) F163-F167
• 32 Chait P, Dinyari M, Massicotte MP. The sensitivity and specificity of lineograms and ultrasound compared to venography for the diagnosis of central venous line related thrombosis in symptomatic children: the LUV study. Thromb Haemost 2001; 86 (Suppl) 697
• 33 Male C, Chait P, Ginsberg JS , et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase. Thromb Haemost 2002; 87 (4) 593-598
• 34 Roy M, Turner-Gomes S, Gill G. Incidence and diagnosis of neonatal thrombosis associated with umbilical venous catheters. Thromb Haemost 1997; 78: 724
• 35 Glaser DW, Medeiros D, Rollins N, Buchanan GR. Catheter-related thrombosis in children with cancer. J Pediatr 2001; 138 (2) 255-259
• 36 Mitchell LG, Andrew M, Hanna K , et al; Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase Group (PARKAA). A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer 2003; 97 (2) 508-516
• 37 Mitchell LG, Sutor AH, Andrew M. Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment. Semin Thromb Hemost 1995; 21 (4) 390-401
• 38 Nowak-Göttl U, Heinecke A, von Kries R, Nürnberger W, Münchow N, Junker R. Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration. Thromb Res 2001; 103 (3) 165-172
• 39 Sutor AH, Mall V, Thomas KB. Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol. Klin Padiatr 1999; 211 (4) 201-204
• 40 Beck C, Dubois J, Grignon A, Lacroix J, David M. Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care unit: a prospective study. J Pediatr 1998; 133 (2) 237-241
• 41 Krafte-Jacobs B, Sivit CJ, Mejia R, Pollack MM. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Pediatr 1995; 126 (1) 50-54
• 42 Cienfuegos JA, Dominguez RM, Tamelchoff PJ , et al. Surgical complications in the postoperative period of liver transplantation in children. Transplant Proc 1984; 16 (5) 1230-1235
• 43 Harmon WE, Stablein D, Alexander SR, Tejani A. Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1991; 51 (2) 406-412
• 44 Krom RA, Wiesner RH, Rettke SR , et al. The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc 1989; 64 (1) 84-94
• 45 McDonald RA, Smith JM, Stablein D, Harmon WE. Pretransplant peritoneal dialysis and graft thrombosis following pediatric kidney transplantation: a NAPRTCS report. Pediatr Transplant 2003; 7 (3) 204-208
• 46 SPLIT Research Group. Studies of Pediatric Liver Transplantation (SPLIT): year 2000 outcomes. Transplantation 2001; 72 (3) 463-476
• 47 Andrew M, Marzinotto V, Pencharz P , et al. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. J Pediatr 1995; 126 (3) 358-363
• 48 Dollery CM, Sullivan ID, Bauraind O, Bull C, Milla PJ. Thrombosis and embolism in long-term central venous access for parenteral nutrition. Lancet 1994; 344 (8929) 1043-1045
• 49 Moukarzel AA, Haddad I, Ament ME , et al. 230 patient years of experience with home long-term parenteral nutrition in childhood: natural history and life of central venous catheters. J Pediatr Surg 1994; 29 (10) 1323-1327
• 50 Buck JR, Connors RH, Coon WW, Weintraub WH, Wesley JR, Coran AG. Pulmonary embolism in children. J Pediatr Surg 1981; 16 (3) 385-391
• 51 Byard RW, Cutz E. Sudden and unexpected death in infancy and childhood due to pulmonary thromboembolism. An autopsy study. Arch Pathol Lab Med 1990; 114 (2) 142-144
• 52 Emery JL. Pulmonary embolism in children. Arch Dis Child 1962; 37 (196) 591-595
• 53 Jones RH, Sabiston Jr DC. Pulmonary embolism in childhood. Monogr Surg Sci 1966; 3 (1) 35-51
• 54 Monagle P, Newall F, Campbell J. Anticoagulation in neonates and children: pitfalls and dilemmas. Blood Rev 2010; 24 (4–5) 151-162
• 55 Chan AK, Deveber G, Monagle P, Brooker LA, Massicotte PM. Venous thrombosis in children. J Thromb Haemost 2003; 1 (7) 1443-1455
• 56 Greenway A, Massicotte MP, Monagle P. Neonatal thrombosis and its treatment. Blood Rev 2004; 18 (2) 75-84
• 57 Kramer SS, Taylor GA, Garfinkel DJ, Simmons MA. Lethal chylothoraces due to superior vena caval thrombosis in infants. AJR Am J Roentgenol 1981; 137 (3) 559-563
• 58 Le Coultre C, Oberhänsli I, Mossaz A, Bugmann P, Faidutti B, Belli DC. Postoperative chylothorax in children: differences between vascular and traumatic origin. J Pediatr Surg 1991; 26 (5) 519-523
• 59 Kurekci E, Kaye R, Koehler M. Chylothorax and chylopericardium: a complication of a central venous catheter. J Pediatr 1998; 132 (6) 1064-1066
• 60 Goldenberg NA, Donadini MP, Kahn SR , et al. Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica 2010; 95 (11) 1952-1959
• 61 Obladen M, Ernst D, Feist D, Wille L. Portal hypertension in children following neonatal umbilical disorders. J Perinat Med 1975; 3 (2) 101-104
• 62 Vos LJ, Potocky V, Bröker FH, de Vries JA, Postma L, Edens E. Splenic vein thrombosis with oesophageal varices: a late complication of umbilical vein catheterization. Ann Surg 1974; 180 (2) 152-156
• 63 Wesström G. Umbilical artery catheterization in newborns. V. A clinical follow-up study. Acta Paediatr Scand 1980; 69 (3) 371-376
• 64 Roy M, Turner-Gomes S, Gill G, Way C, Mernagh J, Schmidt B. Accuracy of Doppler echocardiography for the diagnosis of thrombosis associated with umbilical venous catheters. J Pediatr 2002; 140 (1) 131-134
• 65 Shankar KR, Abernethy LJ, Das KS , et al. Magnetic resonance venography in assessing venous patency after multiple venous catheters. J Pediatr Surg 2002; 37 (2) 175-179
• 66 Andrew M, Monagle P, Brooker L. Pulmonary embolism in childhood. Thromboembolic Complications During Infancy and Childhood. Hamilton/London: B.C. Decker Inc.; 2000: 147-164
• 67 Van Ommen CH, Peters M. Acute pulmonary embolism in childhood. Thromb Res 2006; 118 (1) 13-25
• 68 Wells PS, Ginsberg JS, Anderson DR , et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998; 129 (12) 997-1005
• 69 Wells PS, Anderson DR, Rodger M , et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83 (3) 416-420
• 70 Biss TT, Brandão LR, Kahr WH, Chan AK, Williams S. Clinical probability score and D-dimer estimation lack utility in the diagnosis of childhood pulmonary embolism. J Thromb Haemost 2009; 7 (10) 1633-1638
• 71 Rajpurkar M, Warrier I, Chitlur M , et al. Pulmonary embolism-experience at a single children's hospital. Thromb Res 2007; 119 (6) 699-703
• 72 Biss TT, Brandão LR, Kahr WH, Chan AK, Williams S. Clinical features and outcome of pulmonary embolism in children. Br J Haematol 2008; 142 (5) 808-818
• 73 Andrew M. The hemostatic system in the infant. In: Nathan D, Oski F, eds. Hematology of Infancy and Childhood. Philadelphia: Saunders, W.B; 1992: 115-154
• 74 Andrew M, Schmidt B, Mitchell L, Paes B, Ofosu F. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost 1990; 63 (1) 27-30
• 75 Andrew M, Mitchell L, Vegh P, Ofosu F. Thrombin regulation in children differs from adults in the absence and presence of heparin. Thromb Haemost 1994; 72 (6) 836-842
• 76 Ignjatovic V, Summerhayes R, Gan A , et al. Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate?. Thromb Res 2007; 120 (3) 347-351
• 77 Ignjatovic V, Furmedge J, Newall F , et al. Age-related differences in heparin response. Thromb Res 2006; 118 (6) 741-745
• 78 Newall F, Ignjatovic V, Johnston L , et al. Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin. Thromb Haemost 2010; 103 (5) 1085-1090
• 79 Newall F, Ignjatovic V, Summerhayes R , et al. In vivo age dependency of unfractionated heparin in infants and children. Thromb Res 2009; 123 (5) 710-714
• 80 Ignjatovic V, Straka E, Summerhayes R, Monagle P. Age-specific differences in binding of heparin to plasma proteins. J Thromb Haemost 2010; 8 (6) 1290-1294
• 81 Ignjatovic V, Summerhayes R, Than J, Gan A, Monagle P. Therapeutic range for unfractionated heparin therapy: age-related differences in response in children. J Thromb Haemost 2006; 4 (10) 2280-2282
• 82 Newall F, Johnston L, Ignjatovic V, Summerhayes R, Monagle P. Age-related plasma reference ranges for two heparin-binding proteins—vitronectin and platelet factor 4. Int J Lab Hematol 2009; 31 (6) 683-687
• 83 Hirsh J. Heparin. N Engl J Med 1991; 324 (22) 1565-1574
• 84 Monagle P, Ignjatovic V, Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev 2010; 24 (2) 63-68
• 85 Schmidt B, Gillie P, Mitchell L, Andrew M, Caco C, Roberts R. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1998; 158 (2) 470-476
• 86 Newall F, Ignjatovic V, Johnston L , et al. Clinical use of unfractionated heparin therapy in children: time for change?. Br J Haematol 2010; 150 (6) 674-678
• 87 Kuhle S, Eulmesekian P, Kavanagh B , et al. Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill children. Haematologica 2007; 92 (4) 554-557
• 88 Mitchell LG, Vegh P. Conventional chromogenic heparin assays are influenced by patient's endogenous plasma Antithrombin levels. Klin Padiatr 2010; 222 (3) 164-167
• 89 McDonald MM, Jacobson LJ, Hay Jr WW, Hathaway WE. Heparin clearance in the newborn. Pediatr Res 1981; 15 (7) 1015-1018
• 90 Turner-Gomes S, Nitschmann E, Benson L , et al. Heparin is cleared faster in children with congenital heart disease than adults. J Am Coll Cardiol 1993; 21 (2) 59a
• 91 Andrew M, Marzinotto V, Massicotte P , et al. Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res 1994; 35 (1) 78-83
• 92 Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial. Ann Intern Med 1993; 119 (9) 874-881
• 93 Cruickshank MK, Levine MN, Hirsh J, Roberts R, Siguenza M. A standard heparin nomogram for the management of heparin therapy. Arch Intern Med 1991; 151 (2) 333-337
• 94 Monagle P, Chalmers E, Chan A , et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl) 887S-968S
• 95 Kuhle S, Eulmesekian P, Kavanagh B, Massicotte P, Vegh P, Mitchell LG. A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study. Haematologica 2007; 92 (2) 244-247
• 96 Murphy MS, John PR, Mayer AD, Buckels JA, Kelly DA. Heparin therapy and bone fractures. Lancet 1992; 340 (8827) 1098
• 97 Sackler JP, Liu L. Heparin-induced osteoporosis. Br J Radiol 1973; 46 (547) 548-550
• 98 Rauch F, Travers R, Plotkin H, Glorieux FH. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 2002; 110 (9) 1293-1299
• 99 Shaughnessy SG, Young E, Deschamps P, Hirsh J. The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria. Blood 1995; 86 (4) 1368-1373
• 100 Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?. Am J Hematol 2007; 82 (12) 1037-1043
• 101 Selleng S, Malowsky B, Strobel U , et al. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost 2010; 8 (1) 30-36
• 102 Boshkov L, Ibsen L, Kirby A, Ungerleider R. I S. Heparin-induced thrombocytopenia (HIT) in neonates and very young children undergoing congenital cardiac surgery: a likely under-recognized complication with significant morbidity and mortality: report of 4 sequential cases. J Thromb Haemost 2003; 1 (Suppl 1) 1494a
• 103 Etches W, Stang L, Conradi A. Incidence of heparin-induced thrombocytopenia in a pediatric intensive care population. Blood 2003; 102 (11) (Suppl) 536a
• 104 Klenner AF, Lubenow N, Raschke R, Greinacher A. Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature. Thromb Haemost 2004; 91 (4) 719-724
• 105 Newall F, Barnes C, Ignjatovic V, Monagle P. Heparin-induced thrombocytopenia in children. J Paediatr Child Health 2003; 39 (4) 289-292
• 106 Schmugge M, Risch L, Huber AR, Benn A, Fischer JE. Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics 2002; 109 (1) E10
• 107 Spadone D, Clark F, James E, Laster J, Hoch J, Silver D. Heparin-induced thrombocytopenia in the newborn. J Vasc Surg 1992; 15 (2) 306-311 , discussion 311–312